MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/102.5/0.1/21.03.25 | Real-time Bid/Ask 10:45:44 27/06/2024 pm IST | ||
| 0.095 EUR / 0.097 EUR | -7.69% |
|
| Current month | +13.04% | ||
| 1 month | +11.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 0.094 | -9.62% |
| 26/24/26 | 0.104 | -4.59% |
| 25/24/25 | 0.109 | +3.81% |
| 24/24/24 | 0.105 | 0.00% |
| 21/24/21 | 0.105 | +3.96% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 09:01 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | Morgan Stanley |
| WKN | MG4PAP |
| ISIN | DE000MG4PAP5 |
| Date issued | 23/05/2024 |
| Strike | 102.5 $ |
| Maturity | 21/03/2025 (267 Days) |
| Parity | 10 : 1 |
| Emission price | 0.15 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.121 € |
|---|---|
| Lowest since issue | 0.07 € |
| Delta | 0.14x |
| Omega | 10.18 |
| Premium | 32.16x |
| Gearing | 75.43x |
| Moneyness | 0.7643 |
| Difference Strike | 24.13 $ |
| Difference Strike % | +23.54% |
| Spread | 0.002 € |
| Spread % | 2.04% |
| Theoretical value | 0.0970 |
| Implied Volatility | 24.73 % |
| Total Loss Probability | 90.32 % |
| Intrinsic value | 0.000000 |
| Present value | 0.0970 |
| Break even | 103.54 € |
| Theta | -0x |
| Vega | 0.01x |
| Rho | 0.01x |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
158.5
USD
Average target price
174.4
USD
Spread / Average Target
+10.04%
- Stock Market
- Warrants
- Warrant
